During the course of her career, Ms. Halevi has managed numerous aspects of medical device clinical trials and regulatory affairs processes, including preparation and submission of more than 25 U.S. 510(k) applications and U.S. premarket approval submissions.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
